Expert Exchange: SpaceX plummets back down to earth after explosive IPO debut
SpaceX has revisited its $135 listing price after an explosive IPO as investors reassess lofty valuations ahead of its first earnings report.
Market Cap $58.13M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 15.57pm 27/07/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 26.0¢ | Day High | 27.0¢ | Day Low | 26.0¢ | |||
| Daily Volume | 215985 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 26.5¢ | 7770 | 0 | 27.0¢ | 70202 | |
Directors & Senior Management
| Ms. Amanda Bryce | Member of Pharmacy Advisory Board |
| Mr. Blair William Brabin Vega Norfolk | MD, CEO & Director |
| Mr. Cameron Unsworth | Member of Pharmacy Advisory Board |
| Ms. Catherine Bronger | Member of Pharmacy Advisory Board |
| Ms. Dominique Gayle Fisher | Independent Non-Executive Director |
| Dr. Emanuelle Maguin | Member of Scientific Advisory Board |
| Mr. Geoffrey Joseph Sam | Independent Non-Executive Chairman |
| Mr. George Lazarou | Company Secretary |
| Dr. Gerard Karsenty | Member of Scientific Advisory Board |
| Dr. Jaroslav Haman Boublik | Chief Science Officer & Member of Scientific Advisory Board |
| Prof. John Funder | Member of Scientific Advisory Board |
| Ms. Lauren Dwyer | Chief Financial Officer |
| Dr. Marco Pane | Member of Scientific Advisory Board |
Data source: ADVFN
